Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19929328 | 0.86 | ALDH1A1 (0.35) | ALDH1A1MEN1KMT2AL3MBTL1SCN9A | |
| SCHEMBL26391159 | 0.82 | ALDH1A1 (0.34) | ALDH1A1MEN1KMT2AL3MBTL1SCN9A | |
| SCHEMBL12093457 | 0.82 | SCN9A (0.37) | ALDH1A1MEN1KMT2AL3MBTL1SCN9A | |
| SCHEMBL19929336 | 0.81 | NPSR1 (0.40) | ALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL12093459 | 0.81 | ALDH1A1 (0.49) | ALDH1A1MEN1KMT2AL3MBTL1SCN9A | |
| SCHEMBL12869523 | 0.72 | MEN1 (0.33) | ALDH1A1MEN1KMT2A | |
| SCHEMBL12409937 | 0.72 | ALDH1A1 (0.36) | ALDH1A1MEN1KMT2AL3MBTL1SCN9A | |
| SCHEMBL26391324 | 0.72 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1SCN9A | |
| SCHEMBL19929335 | 0.71 | CYP17A1 (0.36) | — | |
| SCHEMBL19929363 | 0.71 | CYP17A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180065924-A1 | SALT AND PHOTORESIST COMPOSITION CONTAINING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180065924-A1 | SALT AND PHOTORESIST COMPOSITION CONTAINING THE SAME | C1R, RER1, C1S | ALDH1A1 2788/4885MEN1 1096/4885KMT2A 654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.